Top Purchase Related
Home
>
Node
>
Subnode

Mild von type i von Willebrand disease

Nordmann, A.

Praxis 87(21): 747-748

1998

ISSN/ISBN: 1661-8157
PMID: 9643099
Document Number: 488973

Document emailed within 1 workday
Secure & encrypted payments

Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Vicente, V.; Alegre, A.; Alberca, I. 1987: Use of desmopressin in the treatment of mild forms of hemophilia a and von Willebrand's disease Medicina Clinica 88(9): 353-355
Ockelford, P.A.; Menon, N.C.; Berry, E.W. 1980: Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia New Zealand Medical Journal 92(672): 375-378
Miller, J.L. 1996: Platelet-type von Willebrand disease Thrombosis and Haemostasis 75(6): 865-869
Habart, D. 2003: Von Willebrand disease type 2N (Normandy) Vnitrni Lekarstvi 49(4): 253-255
Inocêncio, G.; Braga, A.; Azevedo, S.; Buchner, G. 2013: Management of von Willebrand disease type 3 during pregnancy - 2 cases reports European Review for Medical and Pharmacological Sciences 17(21): 2857-2859
Coughlan, T.C.; Blagg, J.L.; Abulola, M.; Daly, M.E.; Hampton, K.K.; Makris, M.; Peake, I.R.; Goodeve, A.C. 1999: Null alleles are not a common cause of type 1 von Willebrand disease in the British population Thrombosis and Haemostasis 82(4): 1373-1375
Gadisseur, A.P.; Vrelust, I.; Vangenechten, I.; Schneppenheim, R.; Van der Planken, M. 2007: Identification of a novel candidate splice site mutation (0874 + 1G > A) in a type 3 von Willebrand disease patient Thrombosis and Haemostasis 98(2): 464-466
Hilbert, L.; Federici, A.B.; Baronciani, L.; Dallagiovanna, S.; Mazurier, C. 2004: A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications Haematologica 89(9): 1128-1133
Silva, C.D.; Geraldes, F.; Silva, I.S. 2013: Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type IIi von Willebrand disease BMJ Case Reports
Francesconi, M.A.; Deana, R.; Girolami, A.; Pontara, E.; Casonato, A. 1993: Platelet aggregation induced by plasma from type IIB von Willebrand's disease patients is associated with an increase in cytosolic Ca2+ concentration Thrombosis and Haemostasis 70(4): 697-701
Castaman, G.; Eikenboom, J.C.; Bertina, R.M.; Rodeghiero, F. 1999: Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation Thrombosis and Haemostasis 82(3): 1065-1070
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907
Fukui, H.; Yoshioka, A.; Mikami, S.; Takase, T.; Fujimura, Y.; Takahashi, Y.; Nishino, M.; Iwagaki, K. 1979: Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 839-850
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIIi in von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(1): 165-172